Display options
Cite
Moradi A, Nadji SA, Tabarsi P, et al. Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran. Tanaffos. 2011;10(1):8-11
Moradi, A., Nadji, S. A., Tabarsi, P., Hashemian, S. M., Marjani, M., Sigaroodi, A., Mansouri, D., Masjedi, M., & Velayati, A. A. (2011). Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran. Tanaffos, 10(1), 8-11.
Moradi, Ahmadreza, et al. "Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran." Tanaffos vol. 10,1 (2011): 8-11.
Moradi A, Nadji SA, Tabarsi P, Hashemian SM, Marjani M, Sigaroodi A, Mansouri D, Masjedi M, Velayati AA. Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran. Tanaffos. 2011;10(1):8-11. PMID: 25191344; PMCID: PMC4153134.
Copy Download .nbib Format: NLM
Share it on

Tanaffos. 2011;10(1):8-11.

Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran.

Tanaffos

Ahmadreza Moradi, Seyed Alireza Nadji, Payam Tabarsi, Seyed Mohammadreza Hashemian, Majid Marjani, Afsaneh Sigaroodi, Davood Mansouri, Mohammadreza Masjedi, Ali Akbar Velayati

Affiliations

  1. Virology Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, TEHRAN-IRAN.
  2. Mycobacteriology Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, TEHRAN-IRAN.
  3. Nursing and Respiratory Health Management Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, TEHRAN-IRAN.
  4. Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, TEHRAN-IRAN.
  5. Chronic Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, TEHRAN-IRAN.
  6. Pediatric Respiratory Disease Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, TEHRAN-IRAN.

PMID: 25191344 PMCID: PMC4153134

Abstract

BACKGROUND: Oseltamivir-resistant cases were reported during the 2009 pandemic influenza outbreak and therefore, widespread emergence of oseltamivir-resistant 2009 H1N1 virus is imaginable. Underlying medical conditions like immunosuppression increase the chance of oseltamivir resistance.

MATERIALS AND METHODS: In a retrospective cross-sectional study, respiratory tract specimens of confirmed cases of 2009 H1N1 influenza referred to the Masih Daneshvari Hospital were analyzed for presence of H275Y mutation.

RESULTS: From November 2009 through March 2010, oseltamivir-resistant 2009 H1N1 infection was observed and confirmed in 4 patients (including 2 immunocompromised patients) by performing H275Y mutation molecular testing.

CONCLUSION: Close monitoring of resistance to neuraminidase inhibitors is essential in tertiary care centers. The H275Y mutation (oseltamivir-resistant genotype) could appear in the absence or presence of selective drug pressure.

Keywords: H275Y mutation; Oseltamivir-resistance; Pandemic 2009 H1N1 virus

References

  1. Emerg Infect Dis. 2009 Dec;15(12):1970-2 - PubMed
  2. N Engl J Med. 2003 Feb 27;348(9):867-8 - PubMed
  3. MMWR Morb Mortal Wkly Rep. 2009 May 1;58(16):433-5 - PubMed
  4. Science. 2009 Jul 10;325(5937):197-201 - PubMed
  5. Euro Surveill. 2008 Jan 31;13(5): - PubMed
  6. Arch Virol. 2010 May;155(5):717-21 - PubMed
  7. Wkly Epidemiol Rec. 2009 Oct 30;84(44):453-9 - PubMed
  8. N Engl J Med. 2010 Jan 7;362(1):86-7 - PubMed

Publication Types